“Triple negative” is the term used to describe tumors that are ER-negative, PR-negative, and HER2-negative. It’s estimated that about 20% of breast tumors are triple negative. These tumors do not respond to hormone therapy or HER2-targeted therapies. They do, however, respond well to chemotherapy. Also, many clinical trials are now underway looking at new treatments for triple negative tumors. For additional information about triple negative breast cancer, please visit: Triple Negative
Related Videos
Your biopsy report is the roadmap that will help direct your treatment options. It...
After hearing the word cancer, it may initially be hard for you to take in any of the...
The breast cancer treatment options available to you will be determined by the type of...
Breast cancer awareness campaigns have made us all very aware of breast cancer. But...
If you are living with metastatic breast cancer, it’s possible that at some point you will feel...
Many people have never heard of palliative (pronounced pal-lee-uh-tiv) care. Others think...
Treating Metastatic Breast Cancer
There are two primary goals for...
One of the most common questions women diagnosed with metastatic disease ask is: What did I do...
The Anatomy of Recurrence
A breast cancer recurrence can be local,...